Loading profile…
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
Legal name: National Immunotherapy Cancer Research Foundation Inc
DBA: NICRF
EIN 22-3067246 · Snapshot of IRS recognition, filing currency, financial health, and governance.
Supports One Organization
Pays 56% of its spending as grants (latest Form 990).
To provide grants to section 501C3 organizations that advance and improve scientific research in Immunotherapy and to organizations that promote, advance and improve education and support cancer patients
Total Revenue
$390K
FY2024
Total Expenses
$100K
FY2024
Net Assets
$880K
Program Ratio
55.7%
expenses on programs
Employees
0
Volunteers
—
Board Members
4
Voting
4
Independent
8 answers compiled from IRS Form 990, BMF, Pub 78, and the Auto-Revocation List.